IL4 and Cachexia: Even more, suppression of IL-4 mRNA in the liver of cachexia patients with pancreatic cancer [87] and improved performance of carcinoma-bearing mice treated by IL-4 [88] may provide beneficial approaches for pancreatic cancer patients suffering from tumor-induced cachexia in the future.